tert-Butyl 3-bromomethyl-indole-1-carboxylate, 95.0%, 2.5g

5-Fluoro-6-chloroisatin, 95.0%, 250mg

1-[5-(trifluoromethyl)pyridin-2-yl]piperidin-4-amine, 97%, 1g

4-Bromobicyclo[2.2.2]octan-1-ol, 98%, 500mg

(1S,4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, 98%, 250mg

METHYL 2-(3-AZASPIRO[5.5]UNDECAN-9-YL)ACETATE HCL, 95.0%, 5g

HDMC, PEPTIPURE®, min. 99%, 100 g, glass packaging

Piperidine, PEPTIPURE®, min. 99.5%, for peptide synthesis, 500 ml, glass packaging

6-(Trifluoromethoxy)benzo[d]thiazole, 98.0%, 25g

Tetrahydrofuran-3-ylamine hydrochloride, 95.0%, 1g

6-Methyl-2,4-dioxo-3-phenyl-1h,2h,3h,4h-furo[2,3-d]pyrimidine-5-carboxylic acid, 97%, 100mg

N-Benzylfuran-2-carboxamide, 95.0%, 1g

POTASSIUM BROMIDE, 95%, 250g